SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : STOCKS WITH ATTITUDE TEAM - FA/TA AND EVERYTHING ELSE -- Ignore unavailable to you. Want to Upgrade?


To: Sergio H who wrote (1797)1/23/1998 9:22:00 AM
From: Dave H  Read Replies (2) | Respond to of 2377
 
Sergio/All --

Anyone know anything about MAD? Extremely heavy volume yesterday, looks like it's turning around chart-wise...can't find any recent news on it.

-dave



To: Sergio H who wrote (1797)1/23/1998 11:02:00 AM
From: David Graham  Respond to of 2377
 
Sergio,

Man am I glad I listened to a friend of mine (broker) when he had heard DIGL may have to restate earnings. The last couple of days I've been tempted to go in anyway. At any rate could be a good bounce as they are already past over-done.

Grammy



To: Sergio H who wrote (1797)1/23/1998 12:30:00 PM
From: James Strauss  Read Replies (2) | Respond to of 2377
 
FIBR... FAXX...

Sergio and All:

I took advantage of the dips in FIBR and FAXX to add to my positions today... These are "F" word stocks that I like... : >

Jim



To: Sergio H who wrote (1797)1/23/1998 4:58:00 PM
From: David Graham  Read Replies (1) | Respond to of 2377
 
Sergio, Jim and All,

Finally got a confirmation out of IR on DSCO. J&J is the money behind surfaxin research. We should see FDA phase two within 15 days! Would not confirm or deny that it is fast-tracked as ARDS normally results in death but I beleive it qualifies. Would not confirm or deny license talks for Europe.

Grammy